Company Profile
EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, sunglasses, and instruments and equipment in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. It offers lens, eyewear, contact lenses, reading glasses under Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir Optical, eyexpert, iWear, Humanware, Optifog, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native Eyewear and Bolon, and Foster Grant brands. The company also provides vision assessment, eye pathology diagnosis and treatment, finishing equipment, fitting parameter measurement, small tools, and consumables. In addition, it offers SPECTRALIS, a multimodal imaging platform for diagnosis and treatment; RetinAI; Espansione Group; Cellview Imaging; ANTERION, a multidisciplinary all-in-one anterior segment imaging solution for measurements; apparel, footwear and accessories; and high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. Further, the company designs, develops, markets, and maintains diagnostics, refraction, lens edging and mounting instruments for opticians and prescription laboratories, and measurement; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It sells its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and consumers through the network of brick and mortar retail networks and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.
Latest News
Dreame Technology Redefines Hands-free Cleaning with the Launch of the Dreame D30 Ultra Robot Vacuum
AstraZeneca Q2 Core Earnings, Revenue Rise
The9 Names George Lai as CEO
Jiangxi Bio's Veterinary Tetanus Antitoxin Production Line Officially Commenced Production,Accelerating Commercialization of the Animal Antiserum Portfolio
Far-right Australian politician loses appeal in racism case
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Website | https://www.essilorluxottica.com |
| Audit Risk | 4 |
| Board Risk | 5 |
| Overall Risk | 5 |
| Market Cap | 76.45B |
| Trailing P/E | 33.34 |
| Forward P/E | 20.52 |
| Dividend Rate | 4 |
| Dividend Yield | 2.45% |
| Trailing Annual Div. Rate | 4 |
| Trailing Annual Div. Yield | 2.45% |
| Trailing EPS | 4.99 |
| Forward EPS | 8.11 |
| Book Value | 83.96 |
| Price-to-Book | 1.98 |
| Enterprise-to-Revenue | 3.06 |
| Enterprise-to-EBITDA | 15.65 |
| Ex-Dividend Date | 05/05/2026 |
| Earnings Date | |
| Earnings Call Date | 07/28/2026 |
| Revenue Average | 7.81B |
| Revenue Low | 7.66B |
| Revenue High | 7.91B |